Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

TELESTA THERAPEUTICS INC T.TST

"Telesta Therapeutics Inc is a biopharmaceutical company. The Company is engaged in the research, development, manufacturing and commercialization of human health products and technologies."


TSX:TST - Post by User

Bullboard Posts
Comment by diyodton Jun 08, 2012 11:38am
256 Views
Post# 19993336

RE: 07/06/2012 Appendix 3B

RE: 07/06/2012 Appendix 3B

It seems that there was a CDI conversion of 1.4 mill shares back to the TSX. Explains the recent volume? On first glance not necessarily a good sign, however anytime you can dump that many shares on the market and only move down 3 cents, means heavy support as beech has duly noted. It is also interesting, that those in the know, would have seen those shares coming from the AX in May and would have had reason to run the sp down from the .50 level, in anticipation of picking up the coming shares cheaper.

Beech has noted that TD was a big buyer recently. Can anyone confirm if TD was a net seller in May?

Also the employees made out handsomely at this sp level. I have said it before, I think the run down from the 1.50's has a lot to do with employee compensation and talent retention. The cheaper the shares, the more they get. Not?

I like the volume. A lot. Some folks with deep pockets, like the stock at this price... a lot!

https://media.wotnews.com.au/asxann/01303785.pdf

Origin: Appendix 5. Amended 1/7/98, 1/9/99, 1/7/2000, 30/9/2001, 11/3/2002, 1/1/2003, 24/10/2005. Name of entity Bioniche Life Sciences Inc.

ABN 58 802 789 087 We (the entity) give ASX the following information. Part 1 - All issues 1 +Class You must complete the relevant sections (attach sheets if there is not enough space). of +securities issued or to be issued BNC: CDIs BNCAM: Unlisted Common Shares issued 2 Number of +securities issued or to be issued (if known) or maximum number which may be issued BNC: 1,374,217 CDIs were converted to unlisted Common Shares for trading on the TSX.

BNCAM: 137,596 Common Shares issued as company contributions to employee RRSP for the month of April. 3 Principal terms of the +securities (eg, if options, exercise price and expiry date; if partly paid +securities, the amount outstanding and due dates for +convertible payment; if securities, the conversion price and dates for conversion) BNC: CDIs issued on a 1:1 ratio BNCAM: Ordinary unlisted Common Shares + See chapter 19 for defined terms. 24/10/2005 Appendix 3B Page 1 4 Do the +securities rank equally in all respects from the date of allotment with an existing +class of quoted +securities? If the additional securities do not rank equally, please state: • the date from which they do • the extent to which they participate for the next dividend, (in the case of a trust, distribution) or interest payment • the extent to which they do not rank equally, other than in relation to the next dividend, distribution or interest payment BNCAM: The unlisted Common Shares have been issued under the terms of the Company’s Employee Savings Plans.

These unlisted Common Shares rank equally with the CDIs traded on the ASX. 5 Issue price or consideration BNC: 1,374,217 CDIs were converted into unlisted Common Shares at various prices during the month of May, 2012 as a result of transfers from the ASX to the TSX. BNCAM: 137,596 Common Shares were issued at a price of CDN
.50 each.(NTD this is for employee RRSP) 6 Purpose of the issue (If issued as consideration for the acquisition of assets, ....

Bullboard Posts